The nonalcoholic fatty liver disease market is expanding due to rising prevalence of metabolic syndrome and NASH, increasing demand for diagnostics and emerging therapies addressing fibrosis and inflammation. https://www.datamintelligence.com/research-report/nonalcoholic-fatty-liver-disease-market